Alfasigma Announces New Linerixibat Data Across PBC and Liver Disease to be Presented at AASLD's The Liver Meeting 2026
Jemperli approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer
Complicated Urinary Tract Infections Market Set for Expansion by 2036, Supported by Recent Drug Approvals Including GSK/Spero Therapeutics' UTEBZI and Wockhardt's ZAYNICH and Emerging Therapies | DelveInsight
PD-1 and PD-L1 Inhibitors Clinical Trial Pipeline Analysis Demonstrates 180+ Key Companies on the Horizon Expected to Transform the Oncology Space | DelveInsight
Michael Gentile Announces Filing of Early Warning Report Related to Acquisition of Common Shares of Cascadia Minerals Ltd.